Development of vaccines for SARS-CoV-2 [version 1; peer review: 2 approved]
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a fe...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-08-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-991/v1 |